Wearable pediatric stethoscope wins inaugural GCMI Baby SharQ Tank competition.

A team of mechanical, electrical and computing engineers, supported by the Director of Cardiac Intensive Care for Children’s Healthcare of Atlanta, has been named winner of the inaugural GCMI Baby SharQ Tank Pitch Competition for their novel, low cost, wearable pediatric stethoscope.   The interdisciplinary team, including engineers (Dr. Hong Yeo, Dr. Yun-Soung Kim, and…

From Capstone through CREATE-X and on to the precipice of commercialization: Ethos Medical’s medtech journey for its novel spinal guidance system

In 2018, GCMI chronicled one Georgia Tech Capstone team’s effort to end complications from epidural misplacement.   Fast forward more than three years and the promising product dubbed Neuraline has evolved to become a new medtech startup: Ethos Medical. The Ethos team leveraged the supporting elements and mentors within the Georgia Tech CREATE-X program—with assistance…

The State of Preclinical Studies: A Q&A with GCMI’s Director of Scientific Affairs Evan Goldberg

Our lives, personal and professional, bear little resemblance to those we led at the beginning of 2020. Remarkably, in February 2021, U.S. FDA announced the agency “approved, cleared, or authorized a record high of 132 novel medical devices in 2020, surpassing the 40-year high mark we set in 2018 and capping off 10 years of…

StrideLink Walks Quickly Into the Future of Physical Therapy Through CREATE-X and GCMI

How we walk is a key indicator of any injury, recovery pathway and overall health. Clinicians’ analysis for assessment of gait is still done in a highly subjective way with the naked eye. As such, physical therapists struggle to track patients’ recovery and therapeutic process without a technical, objective yet visual solution for gait assessment.…

Why GCMI for your medtech design & development needs? We have established a proven, capital-efficient pathway and process.

A medtech or life science project’s success is dependent on the careful consideration of several intersecting components: technological, clinical, commercial and legal. GCMI follows a structured, phase-gated process that allows for a disciplined, capital efficient medical device design and product development approach.